NCT00521378View on ClinicalTrials.gov

A Single-Blind, Placebo-Controlled, Dose-Ranging Trial of Oral HDV-Insulin in Patients With Type 2 Diabetes Mellitus

CompletedOBSERVATIONAL
Enrollment

6

Participants

Timeline

Start Date

September 17, 2007

Primary Completion Date

October 6, 2007

Study Completion Date

October 6, 2007

Conditions
Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Trial Locations (1)

Unknown

San Antonio

Sponsors
All Listed Sponsors
lead

Diasome Pharmaceuticals

INDUSTRY

NCT00521378 - A Single-Blind, Placebo-Controlled, Dose-Ranging Trial of Oral HDV-Insulin in Patients With Type 2 Diabetes Mellitus | Biotech Hunter | Biotech Hunter